The tumour necrosis factor-α-238A allele increases the risk of chronic HBV infection in European populations

Journal of Viral Hepatitis

Volumn 19, Issue 2, 2012, Pages

  Zheng, M H ^a   Xiao, D D ^a,b   Lin, X F ^a,b   Wu, S J ^a,b   Peng, M M ^a,b   Yu, X Y ^a,b   Liu, W Y ^a,b   Li, L F ^a,b   Shi, K Q ^a   Fan, Y C ^c   Chen, Y P ^a  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

case control study; chronic hepatitis B; meta analysis; polymorphism; tumour necrosis factor 238 gene; tumour necrosis factor 863 gene

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ARTICLE; ASIAN; BIBLIOGRAPHIC DATABASE; CAUCASIAN; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC MODEL; GENETIC RISK; GENOTYPE; HEPATITIS B; HETEROZYGOTE; HUMAN; INFECTION RISK; MEDLINE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B, CHRONIC; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855860978     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01491.x     Document Type: Article

References (21)

1. McMahon BJ,. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49 (5 Suppl): S45-S55.
2. Kao JH,. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol 2002; 17 (6): 643-650.
3. Thio CL, Thomas DL, Carrington M,. Chronic viral hepatitis and the human genome. Hepatology 2000; 31 (4): 819-827. (Pubitemid 30169925)
4. Kim WR, Benson JT, Therneau TM, et al. Changing epidemiology of hepatitis B in a U.S. community. Hepatology 2004; 39 (3): 811-816. (Pubitemid 38337662)
5. Guidotti LG, Ishikawa T, Hobbs MV, et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4 (1): 25-36. (Pubitemid 26054933)
6. Kamizono S, Hiromatsu Y, Seki N, et al. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 2000; 52 (6): 759-764. (Pubitemid 30409269)
7. Kummee P, Tangkijvanich P, Poovorawan Y, et al. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 2007; 14 (12): 841-848. (Pubitemid 350211408)
8. Romero R, Lavine JE,. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996; 23 (1): 17-23. (Pubitemid 26012086)
9. Biermer M, Puro R, Schneider RJ,. Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol 2003; 77 (7): 4033-4042. (Pubitemid 36350944)
10. Hajeer AH, Hutchinson IV,. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 2001; 62 (11): 1191-1199. (Pubitemid 33032271)
11. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94 (7): 3195-3199. (Pubitemid 27157287)
12. Lok AS, McMahon BJ,. Chronic hepatitis B: update 2009. Hepatology 2009; 50: 661-662.
13. Tobias A,. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 8: 15-17.
14. Higgins J, Thompson S, Deeks J, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. (Pubitemid 37088507)
15. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. (Pubitemid 27387172)
16. Chen DQ, Zeng Y, Zhou J, et al. Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population. J Med Virol 2010; 82 (3): 371-378.
17. Niro GA, Fontana R, Gioffreda D, et al. Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. Liver Int 2005; 25 (6): 1175-1181. (Pubitemid 41782562)
18. Hohler T, Kruger A, Gerken G, et al. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111 (3): 579-582. (Pubitemid 28160904)
19. Kim YJ, Lee HS, Yoon JH, et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 2003; 12 (19): 2541-2546. (Pubitemid 37220418)
20. Zheng MH, Qiu LX, Xin YN, et al. Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations. Int J Infect Dis 2010; 14 (7): e580-e585.
21. Miyazoe S, Hamasaki K, Nakata K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002; 97 (8): 2086-2092.